However, cancer cells have been shown to eventually be able to escape from suppression by a TGFBR2 knockout, thus indicating that additional strategies are needed to simultaneously inhibit TGFBR2's “backup partners” such as ERK1/2 (10). Here, TGFBR2 is linked to cancer.